American Skin Association Announces 2026 Research Grants for Advancing Skin Health and Treatments

American Skin Association Unveils 2026 Research Grant Recipients



The American Skin Association (ASA) has recently announced the thirteen recipients of its 2026 research grants, reinforcing its dedication to innovative research targeting skin cancer and various dermatologic diseases. With an impressive history of funding over 300 researchers, ASA continues to identify and support passionate scientists who are on the forefront of skin health advancements.

This year's research grant program marks a significant expansion, incorporating new avenues of study addressing conditions like hidradenitis suppurativa, systemic mastocytosis, and the dermatological effects of anti-obesity medications. By branching into these emerging areas, ASA further demonstrates its commitment to evolving scientific landscapes, ultimately leading to better understanding and treatment of skin conditions.

A standout feature of the 2026 grant cycle is the generous $300,000 contribution from Sun Pharma, which will facilitate three Investigative Scientist Awards, highlighting the importance of corporate partnerships in promoting scientific innovation. Notable recipients of this award include Dr. Benjamin Nanes from UT Southwestern Medical Center, Dr. Scott Stratman from Icahn School of Medicine at Mount Sinai, and Dr. Carl Gustaf Marten Winge from Stanford University. Their projects will focus on various significant aspects of skin disease and treatment.

Four additional Investigative Scientist Awards were granted this year, reflecting the diverse range of research proposals that have been submitted. Among these are Dr. Nicholas Theodosakis from Massachusetts General Hospital, who received the Calder Investigative Award in Vitiligo; Dr. Nicholas Heitman at Icahn School of Medicine, awarded the Blueprint Medicines Investigative Scientist Award in Systemic Mastocytosis; Dr. Nathan Archer from Johns Hopkins School of Medicine, who received the Sanofi Investigative Scientist Award in Atopic Dermatitis; and Dr. Andrew Sawaya from the University of Miami, awarded for his work on Hidradenitis Suppurativa.

In addition to these awards, ASA has also granted the Research Scholar Award in Anti-Obesity Drugs for dermatology to Dr. Helen He from Icahn School of Medicine at Mount Sinai. ASA's commitment to funding research extends beyond individual awards, with multiple grants funded by generous donations from individuals, foundations, and corporations aimed at advancing treatments for various skin disorders.

For nearly 40 years, ASA has been dedicated to addressing the needs of the more than 100 million Americans suffering from skin disorders. The organization has financed over $50 million in grants, aimed at enhancing treatments and seeking cures particularly for melanoma, psoriasis, vitiligo, and atopic dermatitis. ASA's Chairman, Howard P. Milstein, emphasized the crucial role of scientific discovery, noting that improving patient outcomes hinges on continued investment in talented researchers and innovative research areas.

The ASA's Medical Advisory Committee (MAC), composed of leading scientists and physicians, oversees the grant process, ensuring that only the most promising projects receive funding. Under their leadership, ASA has been able to support both emerging researchers and established experts in the dermatology field, indicating a commitment to promoting the science of skin health.

The research proposals from 2026 reflect a diverse and innovative exploration of ideas within dermatology, showcasing the exceptional talent and creativity present in this field. Dr. James Krueger, ASA President and MAC Co-Chair, applauded this year’s cohort of researchers, anticipating that their contributions will lead to significant advancements in understanding and treating skin ailments.

Ultimately, ASA not only aims to fund crucial research but also to shape future generations of scientists and healthcare providers dedicated to dermatology. As they support crucial investigations, they help pave new pathways in skin science that promise transformative results, altering perceptions and outcomes for skin disease management.

The following notable recipients of the 2026 Investigative Scientist Award, along with other prizes, showcase the promising efforts of these researchers and their commitment to altering the landscape of skin health:
  • - Benjamin Nanes, MD, PhD - UT Southwestern Medical Center
Project: Spatial regulation of keratinocyte signaling and transcription during wound healing.

  • - Scott Stratman, MD, MPH, CWSP, FAAD - Icahn School of Medicine at Mount Sinai
Project: Characterizing inflammatory bowel disease–associated pyoderma gangrenosum.

  • - Carl Gustaf Marten Winge, MD, PhD - Stanford University
Project: Oncogene-induced neddylation dependence in cutaneous squamous cell carcinoma.

  • - Nicholas Theodosakis, MD, PhD - Massachusetts General Hospital
Project: Targeting melanosomal proteinopathy in melanophage formation.

  • - Nicholas Heitman, MD, PhD - Icahn School of Medicine
Project: Creation of a spatially resolved single-cell atlas of the cutaneous mast cell niche in mastocytosis.

  • - Nathan Archer, PhD - Johns Hopkins School of Medicine
Project: Restoring the lipid barrier to combat Staphylococcus aureus colonization in atopic dermatitis.

  • - Andrew Sawaya, DOC, MS - University of Miami
Project: Targeting epigenetic priming to prevent disease recurrence in hidradenitis suppurativa.

  • - Helen He, MD - Icahn School of Medicine
Project: Comprehensive profiling of patients treated with glucagon-like peptide-1 receptor agonists.

  • - Lingchen Fu, PhD - Arizona State University
Project: Epidermal SerpinB3 Drives Dermal Immune Activation in Psoriasis.

  • - Jesse Veenstra, MD, PhD, MS - Henry Ford Health System
Project: ANGPTL4 regulates keratinocyte state in early cutaneous squamous cell carcinoma.

  • - Irene Quan - Northwestern University
Project: Evaluating clinical fidelity of generative AI in vitiligo.

For more information about the American Skin Association and its ongoing efforts, please visit americanskin.org.

Together, we can look forward to a future where skin diseases are better understood and treated, improving the lives of countless individuals affected by these conditions.

Topics Health)

【About Using Articles】

You can freely use the title and article content by linking to the page where the article is posted.
※ Images cannot be used.

【About Links】

Links are free to use.